Stock Screener App

Frei -

Installieren

14.63

3.48% 0.56

Keros Therapeutics Inc (KROS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt KROS? Forum Prognose

Finanzdaten der Keros Therapeutics Inc-Aktie (KROS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	41.96% 0.083	0.143	0.008	-	-
Operating Expenses	4.22% 48.57	46.60	43.29	41.34	38.87
Benefits Costs and Expenses	100.00% -	153.14	-	-	-
Costs And Expenses	63.80% 48.57	29.65	43.29	-	-
Operating Income/Loss	4.37% -48.48	-46.45	-43.28	-41.34	-38.87
Nonoperating Income/Loss	13.57% 5.369	6.212	3.84	3.832	3.065
Income/Loss From Continuing Operations Before Tax	100.05% 0.083	-153.00	0.008	-37.51	-35.80
Income/Loss From Continuing Operations After Tax	7.13% -43.11	-40.24	-39.44	-37.51	-35.80
Net Income/Loss	7.13% -43.11	-40.24	-39.44	-37.51	-35.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	15,485% 35.69	0.229	29.67	29.60	28.37
Diluted Average Shares	15,485% 35.69	0.229	29.67	29.60	28.37
Basic Earnings Per Share	9.70% -1.21	-1.34	-1.33	-1.27	-1.26
Diluted Earnings Per Share	9.70% -1.21	-1.34	-1.33	-1.27	-1.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$19.85

0.77%

INSM

$71.22

2.53%

RPRX

$32.51

0.11%

SMMT

$24.83

0.47%

BNTX

$97.38

1.48%

ONC

$231.14

0.63%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters